BioXcel Therapeutics (BTAI) Q3 2024 Earnings

6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.58
-1.12
-0.67
-0.21

Details

Expected EPS
-0.712564
Actual EPS
-0.21
Surprise EPS
0.5
Surprise Percent
+70.53%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -0.21 per share for Q3 2024.

0 Comments

Share your thoughts